Technion Research and Development Foundation

CAPS Medical Ltd, founded in 2018 and based in Netanya, Israel, develops innovative medical devices utilizing non-thermal atmospheric plasma technology for cancer treatment. The company focuses on creating minimally invasive solutions that specifically target solid tumors while preserving surrounding healthy tissue. CAPS Medical originated from a collaboration between the Technion’s Plasma Lab and Rambam Medical Center’s Cancer Lab, aiming to address significant gaps in the oncology therapeutics market. By fine-tuning the energy dose delivered during treatment, CAPS Medical seeks to enhance the effectiveness of cancer therapies and contribute to advancements in cancer care.

Amplio is the first and only Impact Platform for Special Education. We are on a mission to help students with special learning needs reach their full potential. The Amplio Platform including research and evidence-based curricula and programs is designed to deliver intensive, rigorous instruction to prepare students for success, both academically and in their everyday lives. Our solutions are developed in conjunction with parents and a world- class advisory council, academics, and school administrators with expertise in special populations. Tens of thousands of students have received services and interventions using the Amplio platform since the solution was launched in 2019.

Avraham Pharmaceuticals Ltd. is a privately held pharmaceutical company based in Yavne, Israel, established in 2010. The company focuses on developing innovative treatments for neurodegenerative disorders. Its lead product candidate, Ladostigil, is aimed at addressing mild cognitive impairment and is designed to incorporate neuroprotective mechanisms, including the reduction of oxidative stress and microglial activation, as well as the inhibition of pro-inflammatory cytokines. Avraham Pharmaceuticals has raised $9 million to support a European Phase II proof-of-concept efficacy trial for Ladostigil in patients with Alzheimer's disease.

Correlsense is a provider of Application Performance Management software designed to enhance IT reliability by identifying performance issues and outages caused by underperforming applications. Its flagship product, SharePath, offers comprehensive visibility into data center transactions by tracking each interaction through the infrastructure. This enables businesses to optimize user experiences, manage risks during service rollouts and data center migrations, and improve capacity planning. SharePath is suitable for organizations of all sizes and is complemented by an Express edition, which provides free enterprise-class software for monitoring both cloud-based and on-premise applications. Founded in 2005 and privately held, Correlsense focuses on helping IT and business teams diagnose performance problems swiftly and conduct in-depth analytics to foster ongoing improvements.

DigiFlex Ltd. is a company based in Kefar Sava, Israel, that specializes in developing and manufacturing inkjet printing systems for various applications, including flexographic, letterpress, dry-offset, and rotary silk screen printing. Founded in 2005, DigiFlex offers an innovative inkjet-based computer-to-plate (CtP) solution that enhances the quality of analog photopolymer plates while eliminating the need for traditional film and chemical processing. Its proprietary bi-component ink technology, developed through extensive research, allows users to create opaque masks directly on plates, facilitating in-house plate-making and reducing costs and time. DigiFlex distributes its products through a network of distributors across Europe, North America, and the Far East, serving the needs of narrow web application printers. As of late 2017, DigiFlex operates as a subsidiary of P.V. Nano Cell Ltd.

DigiFlex Ltd. is a company based in Kefar Sava, Israel, that specializes in developing and manufacturing inkjet printing systems for various applications, including flexographic, letterpress, dry-offset, and rotary silk screen printing. Founded in 2005, DigiFlex offers an innovative inkjet-based computer-to-plate (CtP) solution that enhances the quality of analog photopolymer plates while eliminating the need for traditional film and chemical processing. Its proprietary bi-component ink technology, developed through extensive research, allows users to create opaque masks directly on plates, facilitating in-house plate-making and reducing costs and time. DigiFlex distributes its products through a network of distributors across Europe, North America, and the Far East, serving the needs of narrow web application printers. As of late 2017, DigiFlex operates as a subsidiary of P.V. Nano Cell Ltd.

Corindus designs, manufactures, and commercializes remote robotic systems for interventional procedures. The company's products include CorPath, which enables physicians to perform catheterization procedures from a remote location away from the radiation zone. The company was formerly known as Navicath, Ltd. Corindus was founded in 2002 and is based in Waltham, Massachusetts.